Основните клинични проучвания са проведени във ферми в няколко държави в Европа и извън ЕС.
For the treatment of BRD, the effect of Zactran was studied in comparison to another macrolide antibiotic (tulathromycin) already authorised in the EU, in cattle already affected by the disease.